Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Kangji Medical Holdings Limited (50J.F)

Compare
0.8250
-0.0050
(-0.60%)
As of 8:22:35 AM GMT+2. Market Open.
Loading Chart for 50J.F
  • Previous Close 0.8300
  • Open 0.8250
  • Bid 0.8250 x --
  • Ask 0.8400 x --
  • Day's Range 0.8250 - 0.8250
  • 52 Week Range 0.5550 - 0.9600
  • Volume 27
  • Avg. Volume 162
  • Market Cap (intraday) 1.045B
  • Beta (5Y Monthly) 0.28
  • PE Ratio (TTM) 13.75
  • EPS (TTM) 0.0600
  • Earnings Date Mar 24, 2025
  • Forward Dividend & Yield 0.03 (3.67%)
  • Ex-Dividend Date May 27, 2025
  • 1y Target Est --

Kangji Medical Holdings Limited, an investment holding company, engages in the design, development, manufacture, and sale of minimally invasive surgical instruments and accessories in Mainland China and internationally. The company offers disposable consumables, such as trocars, uterine manipulator, specimen retrieval bag, incision dilator, powered linear stapler and reloads, endoscopic stapler, suction and irrigation sets, closure forceps, and visual guidance D and C suction probe, as well as polymer ligation clips. It provides disposable electrocoagulation forceps and ultrasonic scalpels soft tissue cutting and hemostatic scalpel, reusable ultrasonic scalpels soft tissue cutting and hemostatic scalpel, and laparoscopic surgical instrument. In addition, the company offers instruments, including 4K UHD fluorescence camera system, 4K-ultra resolution endovision camera system, uterin visual guidance surgical system, ultrasonic soft tissue cutting and hemostatic surgical system, cold light source, morcellator, and insufflator. Its products are used in various specialties, such as obstetrics and gynecology, urology, general surgery, and thoracic surgery. The company sells products to a network of distributors, hospitals, and other customers. The company was founded in 2004 and is headquartered in Hangzhou, China.

www.kangjimedical.com

1,007

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 50J.F

View More

Performance Overview: 50J.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

50J.F
10.00%
HANG SENG INDEX (^HSI)
13.91%

1-Year Return

50J.F
253.12%
HANG SENG INDEX (^HSI)
36.62%

3-Year Return

50J.F
328.86%
HANG SENG INDEX (^HSI)
1.54%

5-Year Return

50J.F
67.77%
HANG SENG INDEX (^HSI)
1.66%

Compare To: 50J.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 50J.F

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    1.05B

  • Enterprise Value

    895.38M

  • Trailing P/E

    13.30

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.67

  • Price/Book (mrq)

    3.02

  • Enterprise Value/Revenue

    7.04

  • Enterprise Value/EBITDA

    9.96

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    57.65%

  • Return on Assets (ttm)

    9.40%

  • Return on Equity (ttm)

    17.38%

  • Revenue (ttm)

    1.01B

  • Net Income Avi to Common (ttm)

    581.44M

  • Diluted EPS (ttm)

    0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.24B

  • Total Debt/Equity (mrq)

    0.13%

  • Levered Free Cash Flow (ttm)

    260.12M

Research Analysis: 50J.F

View More

Company Insights: 50J.F

Research Reports: 50J.F

View More

People Also Watch